Русские видео

Сейчас в тренде

Иностранные видео


Скачать с ютуб Dylan Jovine | EXPLAINED: Recursion’s (RXRX) Recent Acquisition of Exscientia (EXAI) в хорошем качестве

Dylan Jovine | EXPLAINED: Recursion’s (RXRX) Recent Acquisition of Exscientia (EXAI) 6 месяцев назад



Скачать бесплатно и смотреть ютуб-видео без блокировок Dylan Jovine | EXPLAINED: Recursion’s (RXRX) Recent Acquisition of Exscientia (EXAI) в качестве 4к (2к / 1080p)

У нас вы можете посмотреть бесплатно Dylan Jovine | EXPLAINED: Recursion’s (RXRX) Recent Acquisition of Exscientia (EXAI) или скачать в максимальном доступном качестве, которое было загружено на ютуб. Для скачивания выберите вариант из формы ниже:

Загрузить музыку / рингтон Dylan Jovine | EXPLAINED: Recursion’s (RXRX) Recent Acquisition of Exscientia (EXAI) в формате MP3:

Если кнопки скачивания не загрузились НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием, пожалуйста напишите в поддержку по адресу внизу страницы.
Спасибо за использование сервиса ClipSaver.ru



Dylan Jovine | EXPLAINED: Recursion’s (RXRX) Recent Acquisition of Exscientia (EXAI)

Good morning, everyone! Dylan Jovine here with Behind the Markets and for today’s topic—AI in drug discovery. We’ve been following this area closely, and I want to dive into Recursion’s recent acquisition of Exscientia, a move that’s shaking up the biotech space. What’s fascinating is how AI biotech companies like Schrödinger and Recursion are no longer just software providers for big pharma. They’ve transitioned into full-fledged biotech companies, with their value now being driven by their drug pipelines. This shift means they’re being judged by the drugs they develop rather than just the software they sell. Recursion’s merger with Exscientia is a big deal, as it strengthens their drug pipeline with ten promising drugs, most of which could hit a billion dollars in annual sales. Plus, they’re cutting costs and have a strong cash position, setting them up for success as they move forward. This is an exciting time in the AI drug discovery space, and I’m looking forward to seeing how these developments play out. Have a great weekend, and stay tuned for more insights! ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼    / @behindthemarkets   ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/

Comments